AP9801368A0 - Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection - Google Patents

Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection

Info

Publication number
AP9801368A0
AP9801368A0 AP9801368A AP9801368A AP9801368A0 AP 9801368 A0 AP9801368 A0 AP 9801368A0 AP 9801368 A AP9801368 A AP 9801368A AP 9801368 A AP9801368 A AP 9801368A AP 9801368 A0 AP9801368 A0 AP 9801368A0
Authority
AP
ARIPO
Prior art keywords
hiv
mentia
infection
aids virus
benzamide treatment
Prior art date
Application number
AP9801368A
Other versions
AP898A (en
Original Assignee
Centaur Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centaur Pharmaceuticals filed Critical Centaur Pharmaceuticals
Publication of AP9801368A0 publication Critical patent/AP9801368A0/en
Application granted granted Critical
Publication of AP898A publication Critical patent/AP898A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/1998/001368A 1996-04-17 1997-04-17 Benzamidine treatment of dementia associated with Aids Virus (HIV-1) infection. AP898A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1571096P 1996-04-17 1996-04-17
PCT/US1997/006351 WO1997038684A1 (en) 1996-04-17 1997-04-17 Benzamide treatment of dementia associated with aids virus (hiv-1) infection

Publications (2)

Publication Number Publication Date
AP9801368A0 true AP9801368A0 (en) 1998-12-31
AP898A AP898A (en) 2000-11-17

Family

ID=21773101

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001368A AP898A (en) 1996-04-17 1997-04-17 Benzamidine treatment of dementia associated with Aids Virus (HIV-1) infection.

Country Status (11)

Country Link
EP (1) EP0912171A1 (en)
CN (1) CN1218399A (en)
AP (1) AP898A (en)
AU (1) AU720578B2 (en)
BR (1) BR9708720A (en)
CA (1) CA2252403A1 (en)
IS (1) IS4868A (en)
NZ (1) NZ332438A (en)
OA (1) OA10901A (en)
TW (1) TW412421B (en)
WO (1) WO1997038684A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1482909B1 (en) 2002-02-13 2018-07-04 Creagri, Inc. Method and composition for treatment of inflammation
JP6750177B2 (en) * 2015-12-11 2020-09-02 ロート製薬株式会社 Anthranilamide derivative and therapeutic agent for diseases involving TLR3 containing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions
IL117629A (en) * 1995-04-03 2000-08-13 Centaur Pharmaceuticals Inc Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof

Also Published As

Publication number Publication date
AU2732297A (en) 1997-11-07
CN1218399A (en) 1999-06-02
OA10901A (en) 2002-02-14
WO1997038684A1 (en) 1997-10-23
EP0912171A1 (en) 1999-05-06
AP898A (en) 2000-11-17
TW412421B (en) 2000-11-21
NZ332438A (en) 2001-02-23
IS4868A (en) 1998-10-16
CA2252403A1 (en) 1997-10-23
BR9708720A (en) 2000-01-04
AU720578B2 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
EP0831873A4 (en) The treatment of hiv and other viral infections using combinatory therapy
AP9901661A0 (en) Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases
HK1060847A1 (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
PL344223A1 (en) Compositions for the treatment of hiv and other viral infections
CA2072573A1 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
WO2001010456A3 (en) Peptides that block viral infectivity and methods of use thereof
EP1034003A4 (en) Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
NZ310055A (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
NZ307494A (en) Lymphokine capable of inhibiting immunodeficiency viruses
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
GB9304746D0 (en) Treatment of viral infections
HK1050011A1 (en) Treatment of viral infections using levovirintm
HK1044896A1 (en) Method of treating hiv infection and related secondary infections thereof
EE03514B1 (en) A combination of compounds for the treatment of HIV infection or AIDS, its use and a pharmaceutical composition
AU4602897A (en) Method for treatment of immunodeficiency virus infection
AP9801368A0 (en) Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection
AU3530395A (en) Treatment of viral infections
NO965591D0 (en) Combination treatment of HIV infection
IL130160A0 (en) Inactivation of HIV co-receptors as therapy for HIV infection
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
EP0960216A4 (en) Treatment of hiv infection by interfering with host topoisomerase interaction with hiv gag and rt
AU9495098A (en) Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection
OA09648A (en) Immunotherapeutic compositions for treating and preventing AIDS ARC and HIV infection
EP0949915A4 (en) Nitrone free radical trap treatment of dementia associated with aids virus (hiv-1) infection